Menu

#Pharma

14 posts

Feed·
13 of 14 posts
Reed Hastings says Big Tech should get used to being hated — like Big Pharma
🖼️
0Read More

Reed Hastings says Big Tech should get used to being hated — like Big Pharma

All Content from Business Insider·Ben Shimkus·12 minutes ago
#Y8yCaEnp

Reed Hastings, the former Netflix co-CEO, said the tech industry's unpopularity was inevitable — just like Big Pharma.

15s
drug-pipeline-mcp: Open-source pharmaceutical R&D intelligence
🖼️
0Read More

drug-pipeline-mcp: Open-source pharmaceutical R&D intelligence

DEV Community·DasClown·6 months ago
#rQpWkQIF
#mcp#pharma#python#api#pipeline

From Dev.to - python: drug-pipeline-mcp: Open-source pharmaceutical R&D intelligence

15s
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease
🖼️
0Read More

UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

TNW | Health-Tech·Ana-Maria Stanciuc·6 months ago
#lJWJOYir
#facebook#twitter#flipboard#mail#linkedin

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseases are treated. Candid Therapeutics is two years old.…

15s
Colorado to get $75 million from opioid settlement with Purdue Pharma
🖼️
0Read More

Colorado to get $75 million from opioid settlement with Purdue Pharma

Colorado Springs Gazette·Marissa Ventrelli [email protected]·6 months ago
#pPr5bAxa

A $7.4 billion settlement reached with the pharmaceutical company Purdue Pharma and the Sackler family — its owners — is now legally effective a decade after attorneys general from multiple states launched an investigation and seven years after Colorado…

15s
Sun Pharma to acquire Organon for $11.75 bn: How this will expand US footprint, why the timing is significant
📰
0Read More

Sun Pharma to acquire Organon for $11.75 bn: How this will expand US footprint, why the timing is significant

The Indian Express·George Mathew·6 months ago
#DdTvgjZo

The deal comes at a time when the Donald Trump administration is progressively disincentivising foreign pharma manufacturers, especially makers of non-generics and those shopping in drugs from other manufacturing hubs

15s
0Read More

Shaping the future of Japan’s pharmaceutical operations

McKinsey Insights & Publications·7 months ago
#vPaHRkKt
#mckinsey#japan#pharma#industry#global

Japan’s pharma industry, a global innovation leader, faces strain from shifting demand, supply vulnerabilities, and digital disruption. Eight priorities can position it to lead in operations.

15s